Trademark Overview
On Tuesday, January 27, 2026, a trademark application was filed for KANOPREE with the United States Patent and Trademark Office. The USPTO has given the KANOPREE trademark a serial number of 99617559. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, January 27, 2026. This trademark is owned by Karuna Therapeutics, Inc.. The KANOPREE trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment and prevention of obesity, cardiovascular diseases, central nervous system diseases, metabolic disorders, stroke, cancer, inflammatory diseases, respiratory diseases, infectious diseases, auto-immune diseases, solid organ transplant rejection, autoinflammatory disease, blood disease, multiple sclerosis, ulcerative colitis, cystic fibrosis, arthritis, and musculoskeletal and skin disease;; Antivirals; Antibodies for medical purposes; Biological preparations for the treatment of cancer; Anticoagulants; Stem cells for medical purposes; Radiopharmaceutical preparations for the treatment of cancer and solid tumors;; Diagnostic radiopharmaceutical preparations; Diagnostic preparations for medical purposes
